Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-521
Closed -$23.5K 268
2025
Q1
$23.5K Hold
521
﹤0.01% 509
2024
Q4
$31.7K Hold
521
﹤0.01% 506
2024
Q3
$21.3K Hold
521
﹤0.01% 575
2024
Q2
$15.7K Hold
521
﹤0.01% 611
2024
Q1
$19.4K Hold
521
﹤0.01% 587
2023
Q4
$25.6K Hold
521
﹤0.01% 522
2023
Q3
$11.1K Hold
521
﹤0.01% 611
2023
Q2
$7.99K Hold
521
﹤0.01% 668
2023
Q1
$5.87K Hold
521
﹤0.01% 706
2022
Q4
$5.04K Hold
521
﹤0.01% 721
2022
Q3
$10K Buy
+521
New +$13.6K ﹤0.01% 640

Other funds holding AFRM

Washington Trust's AFRM Position: Q2 2025 in Review

Washington Trust sold out of Affirm (AFRM) in Q2 2025, closing a stake of 521 shares — an estimated $23.5K sold.

Washington Trust first reported a position in AFRM in Q3 2022 and held it in 11 quarters. The position peaked at $31.7K in Q4 2024. 561 funds tracked by Wall St. Rank hold AFRM as of Q2 2025.

  • Washington Trust reported no remaining Affirm position as of Q2 2025 after selling out during the quarter.
  • Washington Trust sold 521 Affirm shares in Q2 2025, an estimated $23.5K.
  • Washington Trust first reported a position in Affirm in Q3 2022 and held it in 11 quarters.
  • Washington Trust's Affirm position peaked at $31.7K in Q4 2024.
  • 561 funds tracked by Wall St. Rank held Affirm as of Q2 2025.

Based on Washington Trust's 13F filing for Q2 2025, filed 8 Aug 2025.